364 related articles for article (PubMed ID: 28259789)
1. Evaluation of a serological test for the diagnosis of Borrelia miyamotoi disease in Europe.
Jahfari S; Sarksyan DS; Kolyasnikova NM; Hovius JW; Sprong H; Platonov AE
J Microbiol Methods; 2017 May; 136():11-16. PubMed ID: 28259789
[TBL] [Abstract][Full Text] [Related]
2. Serodiagnosis of Borrelia miyamotoi disease by measuring antibodies against GlpQ and variable major proteins.
Koetsveld J; Kolyasnikova NM; Wagemakers A; Stukolova OA; Hoornstra D; Sarksyan DS; Toporkova MG; Henningsson AJ; Hvidsten D; Ang W; Dessau R; Platonov AE; Hovius JW
Clin Microbiol Infect; 2018 Dec; 24(12):1338.e1-1338.e7. PubMed ID: 29550499
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of a Protein Array for Detection of Antibodies against the Tick-Borne Pathogen Borrelia miyamotoi.
Hoornstra D; Stukolova OA; Karan LS; Sarksyan DS; Kolyasnikova NM; Markelov ML; Cherkashina AS; Dolgova AS; Sudina AE; Sokolova MI; Platonov AE; Hovius JW
Microbiol Spectr; 2022 Dec; 10(6):e0203622. PubMed ID: 36314925
[TBL] [Abstract][Full Text] [Related]
4. Borrelia miyamotoi Disease in the Northeastern United States: A Case Series.
Molloy PJ; Telford SR; Chowdri HR; Lepore TJ; Gugliotta JL; Weeks KE; Hewins ME; Goethert HK; Berardi VP
Ann Intern Med; 2015 Jul; 163(2):91-8. PubMed ID: 26053877
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Borrelia miyamotoi in febrile patients and ticks in Alsace, an endemic area for Lyme borreliosis in France.
Boyer PH; Koetsveld J; Zilliox L; Sprong H; Talagrand-Reboul É; Hansmann Y; de Martino SJ; Boulanger N; Hovius JW; Jaulhac B
Parasit Vectors; 2020 Apr; 13(1):199. PubMed ID: 32303256
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and incidence of antibodies to Borrelia burgdorferi and to tick-borne encephalitis virus in agricultural and forestry workers from Tuscany, Italy.
Tomao P; Ciceroni L; D'Ovidio MC; De Rosa M; Vonesch N; Iavicoli S; Signorini S; Ciarrocchi S; Ciufolini MG; Fiorentini C; Papaleo B
Eur J Clin Microbiol Infect Dis; 2005 Jul; 24(7):457-63. PubMed ID: 15948001
[TBL] [Abstract][Full Text] [Related]
7. Borrelia miyamotoi sensu lato seroreactivity and seroprevalence in the northeastern United States.
Krause PJ; Narasimhan S; Wormser GP; Barbour AG; Platonov AE; Brancato J; Lepore T; Dardick K; Mamula M; Rollend L; Steeves TK; Diuk-Wasser M; Usmani-Brown S; Williamson P; Sarksyan DS; Fikrig E; Fish D;
Emerg Infect Dis; 2014 Jul; 20(7):1183-90. PubMed ID: 24960072
[TBL] [Abstract][Full Text] [Related]
8. Presence of Borrelia miyamotoi infection in a highly endemic area of Lyme disease.
Marcos LA; Smith K; Reardon K; Weinbaum F; Spitzer ED
Ann Clin Microbiol Antimicrob; 2020 May; 19(1):22. PubMed ID: 32473652
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a Borrelia miyamotoi membrane antigen (BmaA) for serodiagnosis of Borrelia miyamotoi disease.
Harris EK; Brandt KS; Van Gundy TJ; Goodrich I; Wormser GP; Armstrong BA; Gilmore RD
Ticks Tick Borne Dis; 2020 Sep; 11(5):101476. PubMed ID: 32723629
[TBL] [Abstract][Full Text] [Related]
10. [Clinical presentation of Ixodes tick-borne borreliosis caused by Borrelia miyamotoi in the context of an immune response to the pathogen].
Platonov AE; Toporkova MG; Kolyasnikova NM; Stukolova OA; Dolgova AS; Brodovikova AV; Makhneva NA; Karan LS; Koetsveld J; Shipulin GA; Maleev VV
Ter Arkh; 2017; 89(11):35-43. PubMed ID: 29260744
[TBL] [Abstract][Full Text] [Related]
11. The first case of imported Borrelia miyamotoi disease concurrent with Lyme disease.
Oda R; Kutsuna S; Sekikawa Y; Hongo I; Sato K; Ohnishi M; Kawabata H
J Infect Chemother; 2017 May; 23(5):333-335. PubMed ID: 28162921
[TBL] [Abstract][Full Text] [Related]
12. Case control study: Serological evidence that Borrelia miyamotoi disease occurs nationwide in Japan.
Sato K; Sakakibara K; Masuzawa T; Ohnishi M; Kawabata H
J Infect Chemother; 2018 Oct; 24(10):828-833. PubMed ID: 30057339
[TBL] [Abstract][Full Text] [Related]
13. Borrelia burgdorferi sl and tick-borne encephalitis virus coinfection in Eastern France.
Boyer PH; Kieffer P; de Martino SJ; Zilliox L; Vogel JY; Jaulhac B; Hansmann Y
Med Mal Infect; 2018 May; 48(3):218-220. PubMed ID: 29449048
[No Abstract] [Full Text] [Related]
14. Borrelia miyamotoi in vectors and hosts in The Netherlands.
Wagemakers A; Jahfari S; de Wever B; Spanjaard L; Starink MV; de Vries HJC; Sprong H; Hovius JW
Ticks Tick Borne Dis; 2017 Mar; 8(3):370-374. PubMed ID: 28065617
[TBL] [Abstract][Full Text] [Related]
15. Serodiagnosis of Louse-Borne relapsing fever with glycerophosphodiester phosphodiesterase (GlpQ) from Borrelia recurrentis.
Porcella SF; Raffel SJ; Schrumpf ME; Schriefer ME; Dennis DT; Schwan TG
J Clin Microbiol; 2000 Oct; 38(10):3561-71. PubMed ID: 11015364
[TBL] [Abstract][Full Text] [Related]
16. Seroreactivity to the C6 Peptide in Borrelia miyamotoi Infections Occurring in the Northeastern United States.
Molloy PJ; Weeks KE; Todd B; Wormser GP
Clin Infect Dis; 2018 Apr; 66(9):1407-1410. PubMed ID: 29149281
[TBL] [Abstract][Full Text] [Related]
17. [Seroprevalence of Borrelia burgdorferi and tick-borne encephalitis virus in a rural area of Samsun, Turkey].
Aslan Başbulut E; Gözalan A; Sönmez C; Cöplü N; Körhasan B; Esen B; Akın L; Ertek M
Mikrobiyol Bul; 2012 Apr; 46(2):247-56. PubMed ID: 22639313
[TBL] [Abstract][Full Text] [Related]
18. Borrelia miyamotoi infection leads to cross-reactive antibodies to the C6 peptide in mice and men.
Koetsveld J; Platonov AE; Kuleshov K; Wagemakers A; Hoornstra D; Ang W; Szekeres S; van Duijvendijk GLA; Fikrig E; Embers ME; Sprong H; Hovius JW
Clin Microbiol Infect; 2020 Apr; 26(4):513.e1-513.e6. PubMed ID: 31404672
[TBL] [Abstract][Full Text] [Related]
19. Glycerophosphodiester Phosphodiesterase Identified as Non-Reliable Serological Marker for
Reiter M; Stelzer T; Schötta AM; Markowicz M; Leschnik M; Harsch A; Reiß E; Kneusel RE; Stockinger H; Stanek G
Microorganisms; 2020 Nov; 8(12):. PubMed ID: 33255178
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of antibodies to tick-borne encephalitis virus and Borrelia burgdorferi sensu lato in samples from patients with abnormalities in the cerebrospinal fluid.
Treib J; Woessner R; Grauer MT; Mueller-Reiland D; Haass A; Schimrigk K
Zentralbl Bakteriol; 1998 Oct; 288(2):253-66. PubMed ID: 9809406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
